Chemomab Therapeutics Ltd. Increase Decrease In Operating Lease Liability
Chemomab Therapeutics Ltd. (CMMB) reported Increase Decrease In Operating Lease Liability of -$35.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-23
- Chemomab Therapeutics Ltd. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$3.00K.
- Chemomab Therapeutics Ltd. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$3.00K, a 125.00% decline year-over-year.
- Chemomab Therapeutics Ltd. increase decrease in operating lease liability for the quarter ending 2022-12-31 was $4.00K.
- Chemomab Therapeutics Ltd. increase decrease in operating lease liability for the quarter ending 2022-09-30 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$35.00K 20-F · filed 2026-03-23 | |||
| 2025-06-30 | $0.00 6-K · filed 2025-08-14 | |||
| 2024-12-31 | $35.00K 20-F · filed 2026-03-23 | |||
| 2024-06-30 | $19.00K 6-K · filed 2025-08-14 | |||
| 2023-12-31 | $13.00K 20-F · filed 2026-03-23 | |||
| 2023-06-30 | -$3.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | -$6.00K 6-K · filed 2024-08-21 | -$2.00K derived: sum of 3 quarters · filed 2025-04-04 | -$2.00K derived: sum of 4 quarters · filed 2025-04-04 |
| 2023-03-31 | -$3.00K 10-Q · filed 2023-05-11 | $1.00K derived: sum of 2 quarters · filed 2025-04-04 | $1.00K derived: sum of 3 quarters · filed 2025-04-04 | -$26.00K derived: sum of 4 quarters · filed 2025-04-04 |
| 2022-12-31 | $4.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $4.00K derived: sum of 2 quarters · filed 2025-04-04 | -$23.00K derived: sum of 3 quarters · filed 2025-04-04 | -$11.00K 20-F · filed 2025-04-04 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | -$27.00K derived: sum of 2 quarters · filed 2023-08-14 | -$15.00K 10-Q · filed 2022-11-10 | -$17.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | -$27.00K derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | -$15.00K 6-K · filed 2023-08-14 | -$17.00K derived: sum of 3 quarters · filed 2024-03-28 | -$17.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $12.00K 10-Q · filed 2023-05-11 | $10.00K derived: sum of 2 quarters · filed 2024-03-28 | $10.00K derived: sum of 3 quarters · filed 2024-03-28 | $10.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | -$2.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | -$2.00K derived: sum of 2 quarters · filed 2024-03-28 | -$2.00K derived: sum of 3 quarters · filed 2024-03-28 | -$2.00K 20-F · filed 2024-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |